Cadence Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cadence Pharmaceuticals Inc inventory turnover ratio, the Cadence Pharmaceuticals Inc's ability to sell and replace its inventory in the fourth quarter 2013, sequentially increased to 8.48 in the fourth quarter 2013, a new company high. Average inventory processing period, for the Cadence Pharmaceuticals Inc in Dec 31 2013 quarter, has decreased to 43 days, compare to 48 days, in the Sep 30 2013 quarter.

Within Healthcare sector 36 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the third quarter 2013, to 469.

CADX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cadence Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CADX Inventory Turnover Ratio	(Dec 31 2013) IV. Quarter	(Sep 30 2013) III. Quarter	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter
Y / Y Inventory Growth	33.06 %	25.03 %	69.09 %	137.52 %	368.16 %
Y / Y Cost of Sales Growth	42.84 %	63.99 %	44.09 %	4910.43 %	317.22 %
Inventory Turnover Ratio (TTM)	8.48	7.65	7.39	7.94	7.72
CADX's Total Ranking	# 469	# 0	# 0	#	#
Average inventory processing period	43	48	49	46	47
Seq. Inventory Growth	41.88 %	-16.73 %	20.3 %	-6.39 %	33.32 %
Seq. Cost of Sales Growth	233.4 %	20.14 %	1.56 %	-64.88 %	282.75 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 4
Healthcare Sector	# 37
Overall Market	# 469

Inventory Turnover Ratio Statistics
High	Average	Low
8.48	6.85	3.46
(Dec 31 2013)		(Jun 30 2012)

CADX Company Profile >> Back to CADX Efficiency Comparisons >> Compare CADX Inventory Turnover Ratio to its Competitors

Financial Statements
Cadence Pharmaceuticals Inc's Inventories	$ 9 Millions	Visit CADX's Balance sheet
Cadence Pharmaceuticals Inc's Cost of Revenues TTM	$ 60 Millions	Visit CADX's Income Statement
What are CADX's Sales?		Visit CADX's Sales by Segment

Other Inventory Turnover Ratios
Cadence Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CADX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CADX's Competitors
Inventory Turnover Ratio for CADX's Suppliers
Inventory Turnover Ratio for CADX's Customers

You may also want to know
CADX's Sales Growth Rates	CADX's Pe Price to earnings ratio	CADX's Receivables Turnover Ratio	CADX's Stock Quote
CADX's Net Income Growth Rates	CADX's Ps Price to Sales ratio	CADX's Sales per Employee	CADX's Asset Turnover Ratio
CADX's Net Margin	CADX's Pb Price to Book ratio	CADX's Financial Strength Ratios	CADX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2013, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Dec 31 2013	Inventories at quarter ending Dec 31 2013
Zeo Scientifix Inc	18.09	$ 0.285 Millions	$ 0 Millions
Insulet Corporation	17.94	$ 134.683 Millions	$ 8 Millions
China Yct International Group, Inc.	17.50	$ 34.258 Millions	$ 2 Millions
Bioxytran Inc	16.16	$ 0.223 Millions	$ 0 Millions
Rockwell Medical inc	16.05	$ 45.720 Millions	$ 3 Millions
Lisata Therapeutics Inc	15.35	$ 12.947 Millions	$ 1 Millions
Vaso Corporation	14.25	$ 28.499 Millions	$ 2 Millions
Fibrocell Science, Inc.	13.95	$ 7.915 Millions	$ 1 Millions
Fonar Corporation	13.90	$ 31.286 Millions	$ 2 Millions
Biolife Solutions Inc	12.32	$ 6.468 Millions	$ 1 Millions
Musclepharm Corporation	11.51	$ 77.685 Millions	$ 7 Millions
Align Technology inc	11.15	$ 166.685 Millions	$ 15 Millions
Perspective Therapeutics Inc	11.00	$ 4.411 Millions	$ 0 Millions
Bohai Pharmaceuticals Group, Inc.	10.42	$ 40.726 Millions	$ 4 Millions
Henry Schein Inc	10.40	$ 11,982.416 Millions	$ 1,152 Millions
Viveve Medical Inc	10.16	$ 1.301 Millions	$ 0 Millions
Clearday Inc	10.01	$ 1.051 Millions	$ 0 Millions
Ufp Technologies Inc	9.31	$ 98.574 Millions	$ 11 Millions
Lineage Cell Therapeutics Inc	8.88	$ 0.793 Millions	$ 0 Millions
Cadence Pharmaceuticals Inc	8.48	$ 59.645 Millions	$ 7 Millions
Infusystem Holdings Inc	8.45	$ 11.274 Millions	$ 1 Millions
Inotiv Inc	8.29	$ 12.357 Millions	$ 1 Millions
Wearable Health Solutions, Inc.	7.75	$ 0.461 Millions	$ 0 Millions
Vertex Pharmaceuticals Inc	7.58	$ 130.277 Millions	$ 17 Millions
Igc Pharma Inc	7.28	$ 3.149 Millions	$ 0 Millions
Nutrastar International Inc.	7.26	$ 9.633 Millions	$ 1 Millions
Sanomedics, Inc.	7.18	$ 0.606 Millions	$ 0 Millions
Micron Solutions Inc	7.18	$ 18.308 Millions	$ 3 Millions
Kewaunee Scientific Corporation	7.16	$ 92.958 Millions	$ 13 Millions
Star Equity Holdings Inc	7.10	$ 31.704 Millions	$ 4 Millions

Date modified: 2026-09-08T15:09:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.